|
1
|
Trinchieri G, Pflanz S and Kastelein RA:
The IL-12 family of heterodimeric cytokines: New players in the
regulation of T cell responses. Immunity. 19:641–644. 2003.
View Article : Google Scholar
|
|
2
|
Vignali DA and Kuchroo VK: IL-12 family
cytokines: Immunological playmakers. Nat Immunol. 13:722–728. 2012.
View Article : Google Scholar :
|
|
3
|
Sun L, He C, Nair L, Yeung J and Egwuagu
CE: Interleukin 12 (IL-12) family cytokines: Role in immune
pathogenesis and treatment of CNS autoimmune disease. Cytokine.
75:249–255. 2015. View Article : Google Scholar :
|
|
4
|
Wang RX, Yu CR, Dambuza IM, Mahdi RM,
Dolinska MB, Sergeev YV, Wingfield PT, Kim SH and Egwuagu CE:
Interleukin-35 induces regulatory B cells that suppress autoimmune
disease. Nat Med. 20:633–641. 2014. View
Article : Google Scholar :
|
|
5
|
Teng MW, Bowman EP, McElwee JJ, Smyth MJ,
Casanova J, Cooper AM and Cua DJ: IL-12 and IL-23 cytokines: From
discovery to targeted therapies for immune-mediated inflammatory
diseases. Nat Med. 21:719–729. 2015. View
Article : Google Scholar
|
|
6
|
De S and Barnes BJ: B cell transcription
factors: Potential new therapeutic targets for SLE. Clin Immunol.
152:140–151. 2014. View Article : Google Scholar
|
|
7
|
Davidson A and Aranow C: Pathogenesis and
treatment of systemic lupus erythematosus nephritis. Curr Opin
Rheumatol. 18:468–475. 2006.
|
|
8
|
Isenberg D and Rahman A: Systemic lupus
erythematosus-2005 annus mirabillis. Nat Clin Pract Rheumatol.
2:145–152. 2006. View Article : Google Scholar
|
|
9
|
Groom JR, Fletcher CA, Walters SN, Grey
ST, Watt SV, Sweet MJ, Smyth MJ, Mackay CR and Mackay F: BAFF and
MyD88 signals promote a lupuslike disease independent of T cells. J
Exp Med. 204:1959–1971. 2007. View Article : Google Scholar :
|
|
10
|
Furie R, Petri M, Zamani O, Cervera R,
Wallace DJ, Tegzová D, Sanchez-Guerrero J, Schwarting A, Merrill
JT, Chatham WW, et al: A phase III, randomized, placebo-controlled
study of belimumab, a monoclonal antibody that inhibits B
lymphocyte stimulator, in patients with systemic lupus
erythematosus. Arthritis Rheum. 63:3918–3930. 2011. View Article : Google Scholar :
|
|
11
|
Furukawa F: Animal models of cutaneous
lupus erythematosus and lupus erythematosus photosensitivity.
Lupus. 6:193–202. 1997. View Article : Google Scholar
|
|
12
|
Cohen PL and Eisenberg RA: Lpr and gld:
Single gene models of systemic autoimmunity and lymphoproliferative
disease. Annu Rev Immunol. 9:243–269. 1991. View Article : Google Scholar
|
|
13
|
Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han
G, Chen G, Hou C, Ma N, Shen B, et al: A novel IL-23p19/Ebi3
(IL-39) cytokine mediates inflammation in lupus-like mice. Eur J
Immunol. 46:1343–1350. 2016. View Article : Google Scholar
|
|
14
|
Vincent FB, Morand EF, Schneider P and
Mackay F: The BAFF/APRIL system in SLE pathogenesis. Nat Rev
Rheumatol. 10:365–373. 2014. View Article : Google Scholar
|
|
15
|
Ma N, Xing C, Xiao H, He Y, Han G, Chen G,
Hou C, Marrero B, Wang Y, Zhang S, et al: BAFF suppresses IL-15
expression in B cells. J Immunol. 192:4192–4201. 2014. View Article : Google Scholar
|
|
16
|
Cervenak L, Magyar A, Boja R and László G:
Differential expression of GL7 activation antigen on bone marrow B
cell subpopulations and peripheral B cells. Immunol Lett. 78:89–96.
2001. View Article : Google Scholar
|
|
17
|
Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han
G, Chen G, Hou C, Zhang L, Ma N, et al: Pre-existing
CD19-independent GL7(−) Breg cells are expanded during inflammation
and in mice with lupus-like disease. Mol Immunol. 71:54–63. 2016.
View Article : Google Scholar
|
|
18
|
Vincent FB, Morand EF and Mackay F: BAFF
and innate immunity: New therapeutic targets for systemic lupus
erythematosus. Immunol Cell Biol. 90:293–303. 2012. View Article : Google Scholar
|
|
19
|
Ma N, Liu X, Xing C, Wang X, Wei Y, Han G,
Chen G, Hou C, Shen B, Li Y, et al: Ligation of metabotropic
glutamate receptor 3 (Grm3) ameliorates lupus-like disease by
reducing B cells. Clin Immunol. 160:142–154. 2015. View Article : Google Scholar
|
|
20
|
Vlahakos D, Foster MH, Ucci AA, Barrett
KJ, Datta SK and Madaio MP: Murine monoclonal anti-DNA antibodies
penetrate cells, bind to nuclei, and induce glomerular
proliferation and proteinuria in vivo. J Am Soc Nephrol.
2:1345–1354. 1992.
|
|
21
|
Avey MT, Fenwick N and Griffin G: The use
of systematic reviews and reporting guidelines to advance the
implementation of the 3Rs. J Am Assoc Lab Anim Sci. 54:153–162.
2015.
|
|
22
|
Xu R, Wang R, Han G, Wang J, Chen G, Wang
L, Li X, Guo R, Shen B and Li Y: Complement C5a regulates IL-17 by
affecting the crosstalk between DC and gammadelta T cells in
CLP-induced sepsis. Eur J Immunol. 40:1079–1088. 2010. View Article : Google Scholar
|
|
23
|
Zheng M, Xing C, Xiao H, Ma N, Wang X, Han
G, Chen G, Hou C, Shen B, Li Y and Wang R: Interaction of CD5 and
CD72 is involved in regulatory T and B cell homeostasis. Immunol
Invest. 43:705–716. 2014. View Article : Google Scholar
|
|
24
|
Xing C, Ma N, Xiao H, Wang X, Zheng M, Han
G, Chen G, Hou C, Shen B, Li Y and Wang R: Critical role for thymic
CD19+CD5+CD1dhiIL-10+
regulatory B cells in immune homeostasis. J Leukoc Biol.
97:547–556. 2015. View Article : Google Scholar
|
|
25
|
Raij L, Azar S and Keane W: Mesangial
immune injury, hypertension, and progressive glomerular damage in
Dahl rats. Kidney Int. 26:137–143. 1984. View Article : Google Scholar
|
|
26
|
Navarra SV, Guzmán RM, Gallacher AE, Hall
S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, León MG, et al:
Efficacy and safety of belimumab in patients with active systemic
lupus erythematosus: A randomised, placebo-controlled, phase 3
trial. Lancet. 377:721–731. 2011. View Article : Google Scholar
|
|
27
|
Martin JC, Baeten DL and Josien R:
Emerging role of IL-17 and Th17 cells in systemic lupus
erythematosus. Clin Immunol. 154:1–12. 2014. View Article : Google Scholar
|
|
28
|
Murphy G, Lisnevskaia L and Isenberg D:
Systemic lupus erythematosus and other autoimmune rheumatic
diseases: Challenges to treatment. Lancet. 382:809–818. 2013.
View Article : Google Scholar
|
|
29
|
Wang X, Liu X, Zhang Y, Wang Z, Zhu G, Han
G, Chen G, Hou C, Wang T, Ma N, et al: Interleukin (IL)-39
[IL-23p19/Epstein-Barr virus-induced 3 (Ebi3)] induces
differentiation/expansion of neutrophils in lupus-prone mice. Clin
Exp Immunol. 186:144–156. 2016. View Article : Google Scholar :
|
|
30
|
Coquery CM, Wade NS, Loo WM, Kinchen JM,
Cox KM, Jiang C, Tung KS and Erickson LD: Neutrophils contribute to
excess serum BAFF levels and promote CD4+ T cell and B
cell responses in lupus-prone mice. PLoS One. 9:e1022842014.
View Article : Google Scholar :
|
|
31
|
Baker KP, Edwards BM, Main SH, Choi GH,
Wager RE, Halpern WG, Lappin PB, Riccobene T, Abramian D, Sekut L,
et al: Generation and characterization of LymphoStat-B, a human
monoclonal antibody that antagonizes the bioactivities of B
lymphocyte stimulator. Arthritis Rheum. 48:3253–3265. 2003.
View Article : Google Scholar
|
|
32
|
Benson MJ, Dillon SR, Castigli E, Geha RS,
Xu S, Lam KP and Noelle RJ: Cutting edge: The dependence of plasma
cells and independence of memory B cells on BAFF and APRIL. J
Immunol. 180:3655–3659. 2008. View Article : Google Scholar
|
|
33
|
Scholz JL, Crowley JE, Tomayko MM, Steinel
N, O'Neill PJ, Quinn WJ III, Goenka R, Miller JP, Cho YH, Long V,
et al: BLyS inhibition eliminates primary B cells but leaves
natural and acquired humoral immunity intact. Proc Natl Acad Sci
USA. 105:15517–15522. 2008. View Article : Google Scholar :
|
|
34
|
Umiker BR, McDonald G, Larbi A, Medina CO,
Hobeika E, Reth M and Imanishi-Kari T: Production of IgG
autoantibody requires expression of activation-induced deaminase in
early-developing B cells in a mouse model of SLE. Eur J Immunol.
44:3093–3108. 2014. View Article : Google Scholar :
|
